Clinical trial
ONO-7436 Phase II Study in Japan
NCT00212602 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00212602 |
|---|---|
| Title | ONO-7436 Phase II Study in Japan |
| Official title | ONO-7436 Phase II Study - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7436 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Japan |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Tumor |
| Intervention type | Drug |
| Interventions | ONO-7436 |
| Enrollment | 420 |
| Start date | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 14, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: